Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis

Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating th...

Full description

Bibliographic Details
Main Authors: Zena Chen, Xuqi Zheng, Xinyu Wu, Jialing Wu, Xiaomin Li, Qiujing Wei, Xi Zhang, Linkai Fang, Ou Jin, Jieruo Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
adalimumab
TNF
gut microbiome
ankylosing spondylitis
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.700570/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.700570/full

Similar Items